Cargando…
Basal Autophagy and Feedback Activation of Akt Are Associated with Resistance to Metformin-Induced Inhibition of Hepatic Tumor Cell Growth
While accumulating evidence has shown that the use of the diabetic drug metformin may be beneficial against various tumors in some epidemiological studies, a few studies failed to show the same beneficial effects. The molecular and cellular mechanisms for these conflicting observations are not clear...
Autores principales: | Yang, Hua, Peng, Yuan-Fei, Ni, Hong-Min, Li, Yuan, Shi, Ying-Hong, Ding, Wen-Xing, Fan, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482411/ https://www.ncbi.nlm.nih.gov/pubmed/26111001 http://dx.doi.org/10.1371/journal.pone.0130953 |
Ejemplares similares
-
Metformin and erlotinib synergize to inhibit basal breast cancer
por: Lau, Ying-Ka Ingar, et al.
Publicado: (2014) -
Metformin promotes histone deacetylation of optineurin and suppresses tumour growth through autophagy inhibition in ocular melanoma
por: Zhuang, Ai, et al.
Publicado: (2022) -
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy
por: del Campo, José A., et al.
Publicado: (2018) -
Sinomenine inhibits the growth of melanoma by enhancement of autophagy via PI3K/AKT/mTOR inhibition
por: Sun, Zheng, et al.
Publicado: (2018) -
Targeting the Enterohepatic Bile Acid Signaling Induces Hepatic Autophagy via a CYP7A1–AKT–mTOR Axis in Mice
por: Wang, Yifeng, et al.
Publicado: (2016)